Natarajan Sethuraman
Direttore Tecnico/Scientifico/R&S presso ENTRADA THERAPEUTICS, INC.
Patrimonio netto: 3 M $ in data 30/06/2024
Posizioni attive di Natarajan Sethuraman
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ENTRADA THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/09/2017 | - |
Storia della carriera di Natarajan Sethuraman
Precedenti posizioni note di Natarajan Sethuraman
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| MERCK & CO., INC. | Direttore/Membro del Consiglio | 01/08/2006 | 01/07/2016 |
| Corporate Officer/Principal | 01/08/2006 | 01/07/2016 | |
Medical Enzymes AG
 Medical Enzymes AG Medical/Nursing ServicesHealth Services Medical Enzymes AG is a privately held innovative biopharmaceutical company with a focus on therapeutically useful enzymes. The company has developed a new product family based on amino acid depleting enzymes. This unique approach is highly effective against cancer - the major target market of Medical Enzymes AG. Medical Enzymes business strategy focuses on the clinical development of therapeutic enzymes until clinical proof of concept and to commercialize those products through collaboration with selected pharmaceutical partners. | Corporate Officer/Principal | - | - |
Formazione di Natarajan Sethuraman
| Indian Agricultural Research Institute | Doctorate Degree |
| Tamilnadu Agricultural University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
| India | 3 |
| Germania | 2 |
Posizioni
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Director/Board Member | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
| Health Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| ENTRADA THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Medical Enzymes AG
Medical Enzymes AG Medical/Nursing ServicesHealth Services Medical Enzymes AG is a privately held innovative biopharmaceutical company with a focus on therapeutically useful enzymes. The company has developed a new product family based on amino acid depleting enzymes. This unique approach is highly effective against cancer - the major target market of Medical Enzymes AG. Medical Enzymes business strategy focuses on the clinical development of therapeutic enzymes until clinical proof of concept and to commercialize those products through collaboration with selected pharmaceutical partners. | Health Services |
- Borsa valori
- Insiders
- Natarajan Sethuraman
- Esperienza
